Neurology news and neurology widget

An article published in The Lancet reports successful results from a phase II trial for oral fumarate (BG00012). The drug was found to significantly reduce disease activity linked to relapsing-remitting multiple sclerosis (RRMS) that was detected by Magnetic Resonance Imaging (MRI). A phase III trial is underway and the researchers are awaiting the results.

Learning a second language is usually difficult and often when we speak it we cannot disguise our origin or accent. However, there are important differences between individuals with regard to the degree to which a second language is mastered, even for people who have lived in a bilingual environment since childhood. Members of the Cognitive Neuroscience Research Group (GRNC) linked to the Barcelona Science Park, have studied these differences.

Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute who first isolated cancer stem cells in adult brain tumors in 2004 have now identified a molecular mechanism that is involved in the development of these cells from which malignant brain tumors may originate. This could offer a target for scientists seeking treatments that would kill malignant brain tumors at their source and prevent them from recurring.